MVIBA Trademark

Trademark Overview

On Tuesday, July 23, 2019, a trademark application was filed for MVIBA with the United States Patent and Trademark Office. The USPTO has given the MVIBA trademark a serial number of 88530309. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 20, 2023. This trademark is owned by Johnson & Johnson. The MVIBA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
mviba

General Information

Serial Number88530309
Word MarkMVIBA
Filing DateTuesday, July 23, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 19, 2019

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 31, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Tuesday, February 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 27, 2022SOU EXTENSION 5 GRANTED
Monday, July 11, 2022SOU EXTENSION 5 FILED
Wednesday, July 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 11, 2022TEAS EXTENSION RECEIVED
Friday, January 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 5, 2022SOU EXTENSION 4 GRANTED
Wednesday, January 5, 2022SOU EXTENSION 4 FILED
Wednesday, January 5, 2022TEAS EXTENSION RECEIVED
Thursday, July 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 29, 2021SOU EXTENSION 3 GRANTED
Tuesday, June 29, 2021SOU EXTENSION 3 FILED
Tuesday, June 29, 2021TEAS EXTENSION RECEIVED
Thursday, November 19, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 17, 2020SOU EXTENSION 2 GRANTED
Tuesday, November 17, 2020SOU EXTENSION 2 FILED
Tuesday, November 17, 2020TEAS EXTENSION RECEIVED
Friday, June 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 24, 2020SOU EXTENSION 1 GRANTED
Wednesday, June 24, 2020SOU EXTENSION 1 FILED
Wednesday, June 24, 2020TEAS EXTENSION RECEIVED
Tuesday, January 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, October 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 11, 2019ASSIGNED TO EXAMINER
Wednesday, July 31, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 26, 2019NEW APPLICATION ENTERED

Related Keywords

mviba diseases anti system metabolic oncologic ophthalmic related intestinal infectious respiratory